ATE258553T1 - Phenyl-substituierte indolizinderivate und deren verwendung als histamin h3 liganden - Google Patents
Phenyl-substituierte indolizinderivate und deren verwendung als histamin h3 ligandenInfo
- Publication number
- ATE258553T1 ATE258553T1 AT01928331T AT01928331T ATE258553T1 AT E258553 T1 ATE258553 T1 AT E258553T1 AT 01928331 T AT01928331 T AT 01928331T AT 01928331 T AT01928331 T AT 01928331T AT E258553 T1 ATE258553 T1 AT E258553T1
- Authority
- AT
- Austria
- Prior art keywords
- phenyl
- substituted
- histamine
- ligands
- indolicine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19407100P | 2000-03-31 | 2000-03-31 | |
US27213701P | 2001-02-28 | 2001-02-28 | |
PCT/US2001/010049 WO2001074814A1 (en) | 2000-03-31 | 2001-03-29 | Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE258553T1 true ATE258553T1 (de) | 2004-02-15 |
Family
ID=26889667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01928331T ATE258553T1 (de) | 2000-03-31 | 2001-03-29 | Phenyl-substituierte indolizinderivate und deren verwendung als histamin h3 liganden |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1268479B1 (de) |
AT (1) | ATE258553T1 (de) |
AU (1) | AU2001255202A1 (de) |
DE (1) | DE60101906T2 (de) |
DK (1) | DK1268479T3 (de) |
ES (1) | ES2213693T3 (de) |
PT (1) | PT1268479E (de) |
TR (1) | TR200400354T4 (de) |
WO (1) | WO2001074814A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7208497B2 (en) | 2001-07-02 | 2007-04-24 | Novo Nordisk A/S | Substituted piperazines and diazepanes |
US6673829B2 (en) | 2001-09-14 | 2004-01-06 | Novo Nordisk A/S | Aminoazetidine,-pyrrolidine and -piperidine derivatives |
JP4619655B2 (ja) | 2001-09-14 | 2011-01-26 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | 新規アミノアゼチジン、−ピロリジンおよび−ピペリジン誘導体 |
JPWO2005077953A1 (ja) * | 2004-02-18 | 2007-10-18 | 萬有製薬株式会社 | 含窒素縮合ヘテロ芳香環誘導体 |
BRPI0517955A (pt) * | 2004-11-01 | 2008-10-21 | Wyeth Corp | indolizinas substituìdas e derivados como agentes de snc |
WO2006077024A2 (en) * | 2005-01-19 | 2006-07-27 | F. Hoffmann-La Roche Ag | 5-aminoindole derivatives |
EP1717235A3 (de) | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidine und -pyrrolidine und ihre Verwendung als Liganden für den Histamin H3-Rezeptor |
ES2375929T3 (es) | 2005-07-04 | 2012-03-07 | High Point Pharmaceuticals, Llc | Antagonistas del receptor histamina h3. |
US7432255B2 (en) * | 2006-05-16 | 2008-10-07 | Hoffmann-La Roche Inc. | 1H-indol-5-yl-piperazin-1-yl-methanone derivatives |
ATE538116T1 (de) | 2006-05-29 | 2012-01-15 | High Point Pharmaceuticals Llc | 3-(1,3-benyodioxol-5-yl)-6- (4- cyclopropylpiperazin-1-yl)-pyridazin, dessen salze und solvate und dessen verwendung als histamin-h3-rezeptorantagonist |
EP2014656A3 (de) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | Neue heterocyclische H3-Antagonisten |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0978512A1 (de) * | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Aryloxy- (oder Arylthio)alkylamine ohne Imidazolring als Histamin-H3-Antagonisten und deren therapeutische Anwendung |
-
2001
- 2001-03-29 DE DE60101906T patent/DE60101906T2/de not_active Expired - Lifetime
- 2001-03-29 DK DK01928331T patent/DK1268479T3/da active
- 2001-03-29 WO PCT/US2001/010049 patent/WO2001074814A1/en active IP Right Grant
- 2001-03-29 PT PT01928331T patent/PT1268479E/pt unknown
- 2001-03-29 ES ES01928331T patent/ES2213693T3/es not_active Expired - Lifetime
- 2001-03-29 AU AU2001255202A patent/AU2001255202A1/en not_active Abandoned
- 2001-03-29 AT AT01928331T patent/ATE258553T1/de not_active IP Right Cessation
- 2001-03-29 TR TR2004/00354T patent/TR200400354T4/xx unknown
- 2001-03-29 EP EP01928331A patent/EP1268479B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK1268479T3 (da) | 2004-04-19 |
ES2213693T3 (es) | 2004-09-01 |
TR200400354T4 (tr) | 2004-04-21 |
DE60101906T2 (de) | 2004-11-04 |
EP1268479A1 (de) | 2003-01-02 |
WO2001074814A1 (en) | 2001-10-11 |
PT1268479E (pt) | 2004-06-30 |
AU2001255202A1 (en) | 2001-10-15 |
EP1268479B1 (de) | 2004-01-28 |
DE60101906D1 (de) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001074815A3 (en) | Phenyl-substituted imidazopyridines | |
ATE465181T1 (de) | Humanisierte anti-cmet-antagonisten | |
ATE248175T1 (de) | Epothilonderivate und ihre verwendung als antitumormittel | |
DE60314500D1 (de) | Diaminopyrimidine und deren verwendung als angiogenesehemmer | |
WO2001074773A3 (en) | Phenyl-substituted indoles as histamine h3-receptor antagonists | |
DK1385825T3 (da) | Substituerede 2-pyridincyclohexan-1,4-diaminderivater | |
ATE350409T1 (de) | Ampholytisches copolymer und dessen verwendung | |
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
IS7782A (is) | Setin píperasín, (1,4) díassepín og 2,5-díasabísýkló (2.2.1) heptön sem histamín H1 og/eða H3 mótlyf eða histamín H3 gagnmótlyf | |
DE60107221D1 (de) | Indolin-2-on derivate und deren verwendung als liganden der ocytocin rezeptoren | |
ATE474828T1 (de) | Aryl substituierte pyridinen, pyrimidinen, pyrazinen und triazinen und deren verwendung | |
DE602005011780D1 (de) | Triazinderivate mit carbamatfunktion | |
ATE258553T1 (de) | Phenyl-substituierte indolizinderivate und deren verwendung als histamin h3 liganden | |
ATE515262T1 (de) | Verwendung von parthenolid-derivaten als antileukämische und zytotoxische mittel | |
ATE327237T1 (de) | Imidazol derivate, ihre herstellung und ihre verwendung | |
ATE343582T1 (de) | Derivate von (6, 7-dihydro -5h-imidazo(1,2 - a)imidazol -3 -sulfonylamino)-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen | |
DE50003566D1 (de) | Haftvermittler | |
SE0301654D0 (sv) | Novel compounds | |
ATE329908T1 (de) | Arylethene-sulfonamid derivate, deren herstellung und deren verwendung als endothelin-antagonisten | |
TR200402030T4 (tr) | İkame edilen I-aminobutan-3-ol-türevleri | |
DE60229414D1 (de) | Verwendung von aplidine in der behandlung von pankreaskrebs | |
DE10108995A1 (de) | Substituierte Pyrimidinon-Derivate als Liganden von Integrinrezeptoren | |
DE60304360D1 (de) | N-aryl-2-oxazolidinone und deren derivate | |
PL430985A1 (pl) | Schody segmentowe | |
ITRM20010648A0 (it) | Linee cellulari per l'incapsidazione di vettori sv40 derivati loro usi e kit che le comprendono. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1268479 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |